A provider's guide to helping patients save on Brimonidine. Covers manufacturer programs, discount cards, generic options, and building cost conversations.
Glaucoma treatment only works if patients actually use their drops. Yet studies consistently show that medication cost is one of the top reasons patients with glaucoma skip doses, stretch refills, or abandon treatment entirely. For a disease with no symptoms until irreversible vision loss occurs, non-adherence due to cost is a preventable tragedy.
Brimonidine is one of the more affordable glaucoma medications in its generic form — but patients don't always know that. And when they're prescribed brand-name Alphagan P, Combigan, or Simbrinza, the sticker shock at the pharmacy counter can derail even the most motivated patient.
This guide gives you the tools to have proactive cost conversations and connect your patients with the right savings programs.
Understanding the price landscape helps you make informed prescribing decisions:
The takeaway: generic Brimonidine 0.2% is extremely affordable. The cost barrier primarily affects patients on brand-name products or combination agents without generic equivalents.
For patients paying cash or facing high copays on generic Brimonidine, discount card programs can reduce costs significantly:
These programs work for anyone — insured or uninsured. For some patients, a discount card price may actually be lower than their insurance copay. Encourage patients to compare both options.
For a comprehensive list, see our patient-facing guide on how to save money on Brimonidine.
When cost is the primary barrier, consider these prescribing strategies:
For most patients, generic Brimonidine 0.2% is clinically appropriate and costs a fraction of brand-name alternatives. At $7–$15 with a discount card, it's one of the most affordable glaucoma medications available. Unless there's a specific clinical reason to use Alphagan P (e.g., preservative sensitivity requiring Purite), starting generic is both evidence-based and cost-effective.
Alphagan P is available in 0.15% and 0.1% concentrations with a gentler preservative. If a patient needs the lower concentration or the Purite formulation, the manufacturer savings program can help offset the brand-name cost. However, for many patients, generic 0.2% with proper instillation technique is well-tolerated.
If even generic Brimonidine is a stretch (uncommon but possible for uninsured patients on fixed incomes), consider:
All of these generics are well under $25 with discount cards. For patients needing combination therapy, prescribing two separate generic drops may be far cheaper than a single brand-name combination product.
Writing "DAW" (dispense as written) or specifying brand-name products when generics are available adds significant cost with limited clinical benefit in most cases. Review your prescribing habits and default to generic when clinically appropriate.
Many providers feel awkward discussing medication costs — but patients overwhelmingly want these conversations. Here's how to make them routine:
Direct patients to these resources when they need extra help:
The most effective glaucoma medication is the one your patient actually uses. For Brimonidine, cost is rarely an insurmountable barrier — generic versions are among the most affordable eye drops available. But patients need to know that, and they need your guidance to navigate the sometimes confusing landscape of brands, generics, and savings programs.
A 30-second cost conversation at the point of prescribing can be the difference between a compliant patient and one who silently abandons therapy. Make it part of your practice.
For more clinical resources and tools to help your patients, visit Medfinder for Providers.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
